ClinicalTrials.gov
public full text
Public Domain
EXOMIND (BTL-995) for Reduction of Binge-eating
The goal of this clinical trial is to evaluate if the treatment with the BTL-995-rTMS device is able to reduce binge eating in adults above the age of 22 years. The main question it aims to answer is: Whether the treatment with the BTL-995-rTMS device reduces binge eating. Participants will be asked to: Undergo six treatments Undergo weight measurements Complete the Binge Eating Scale Complete the Therapy Comfort Questionnaire Complete the Satisfaction Questionnaire
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway#838328
- EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings#1058082
- Binge-Spectrum Eating Disorders and Higher Body Mass Index Are Associated With Greater Negative Attitudes Towards Obesity.#442860
- EXOMIND (BTL-699-2) for Improvement of Mental Well-being#1094759
- The Effect of High vs. Moderate Protein Consumption on Human Health#887208
Record · ID 826195
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive